LSE creators

Number of items: 29.
European Institute
  • Ferrario, Alessandra, Kanavos, Panos (2015). Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124, 39-47. https://doi.org/10.1016/j.socscimed.2014.11.003 picture_as_pdf
  • Ferrario, Alessandra, Kanavos, Panos (2013). Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease.
  • Kanavos, Panos, Ferrario, Alessandra, Vandoros, Sotiris, Anderson, Gerard F. (2013). Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs, 32(4), 753-761. https://doi.org/10.1377/hlthaff.2012.0920
  • Ferrario, Alessandra, Kanavos, Panos (2013). Managed entry agreements for pharmaceuticals: the European experience. EMiNet.
    • LSE
  • Bezverhni, Zinaida, Safta, Vladimir, Chitan, Elena, Ferrario, Alessandra, Habicht, Jarno (2016). Improving access to essential medicines in the Republic of Moldova. Eurohealth, 22(2), 45-47.
    • LSE Health
  • Nashilongo, M.N, Singu, B, Kalemeera, F, Mubita, M, Naikaku, E, Baker, A, Ferrario, Alessandra, Godman, Brian, Achieng, L, Kibuule, D (2017). Assessing adherence to Antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovascular Drugs and Therapy, 31(5-6), 565-578. https://doi.org/10.1007/s10557-017-6756-8
  • Ferrario, Alessandra (2017). Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden. European Journal of Health Economics, 18(9), 1095-1105. https://doi.org/10.1007/s10198-016-0855-5
  • Ferrario, Alessandra, Arāja, Diāna, Bochenek, Tomasz, Čatić, Tarik, Dankó, Dávid, Dimitrova, Maria, Fürst, Jurij, Greičiūtė-Kuprijanov, Ieva, Hoxha, Iris & Jakupi, Arianit et al (2017). The implementation of managed entry agreements in Central and Eastern Europe: findings and implications. PharmacoEconomics, 35(12), 1271-1285. https://doi.org/10.1007/s40273-017-0559-4
  • Mwita, Stanley, Jande, Mary, Marwa, Karol, Hamasaki, Kayo, Katabalo, Deogratius, Burger, Johanita, Godman, Brian, Ferrario, Alessandra, Massele, Amos, Ruganuza, Deodatus (2017). Medicines dispensers' knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania. Journal of Pharmaceutical Health Services Research, https://doi.org/10.1111/jphs.12187
  • Vogler, Sabine, Paris, Valérie, Ferrario, Alessandra, Wirtz, Veronika J., Joncheere, Kees de, Schneider, Peter, Pedersen, Hanne Bak, Dedet, Guillaume, Babar, Zaheer-Ud-Din (2017). How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries. Applied Health Economics and Health Policy, 15(3), 307-321. https://doi.org/10.1007/s40258-016-0300-z
  • Gyawali, Bishal, Ferrario, Alessandra, van Teijlingen, Edwin, Kallestrup, Per (2016). Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Global Health Action, 9(1). https://doi.org/10.3402/gha.v9.31704
  • Ferrario, Alessandra, Reinap, Marge, Pedersen, Hanne Bak, Kanavos, Panos (2016). Availability of medicines in Estonia: an analysis of existing barriers and options to address them. World Health Organization.
  • Ferrario, Alessandra, Chitan, Elena, Seicas, Rita, Sautenkova, Nina, Bezverhni, Zinaida, Kluge, Hans, Habicht, Jarno (2016). Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova. Health Policy and Planning, 31(6), 793-800. https://doi.org/10.1093/heapol/czv136
  • Ferrario, Alessandra, Kanavos, Panos, Humbert, Tifenn, Iwamoto, Kotoji, Bak Pedersen, Hanne (2016). Challenges and opportunities in improving access to medicines through efficient public procurement in WHO European Region. World Health Organization.
  • Ferrario, Alessandra, Kanavos, Panos (2015). Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124, 39-47. https://doi.org/10.1016/j.socscimed.2014.11.003 picture_as_pdf
  • Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J, Babar, Zaheer-Ud-Din (2015). Challenges and opportunities for pharmaceutical pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice, 8(Suppl). https://doi.org/10.1186/2052-3211-8-S1-E1
  • Ferrario, Alessandra, Baltezarević, Dragana, Novakovic, Tanja, Parker, Mark, Samardzic, Janko (2014). Evidence-based decision making in healthcare in Central Eastern Europe. Expert Review of Pharmacoeconomics and Outcomes Research, 14(5), 611-615. https://doi.org/10.1586/14737167.2014.946014
  • Skarphedinsdottir, Maria, Smith, Barton, Ferrario, Alessandra, Zues, Olga, Ciobanu, Angela, Tirdea, Marcela, Domente, Silviu, Habicht, Jarno (2014). Better noncommunicable disease outcomes: challenges and opportunities for health systems: Republic of Moldova country assessment. World Health Organization.
  • Kwong, Danica, Ferrario, Alessandra, Adamski, Jajub, Inotai, Andras, Kalo, Zoltan (2014). Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth, 20(2), 25-28.
  • Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos, Safta, Vladimir (2014). An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7(1), p. 4. https://doi.org/10.1186/2052-3211-7-4
  • Lamri, Larbi, Gripiotis, Erofile, Ferrario, Alessandra (2014). Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications. Globalization and Health, 10(1), p. 11. https://doi.org/10.1186/1744-8603-10-11
  • Soewondo, Pradana, Ferrario, Alessandra, Tahapary, Dicky Levenus (2013). Challenges in diabetes management in Indonesia: a literature review. Globalization and Health, 9(1), p. 63. https://doi.org/10.1186/1744-8603-9-63
  • Bertoldi, Andréa D., Kanavos, Panos, França, Giovanny V. A., Carraro, André, Tejada, Cesar Augusto, Hallal, Pedro C., Ferrario, Alessandra, Schmidt, Maria (2013). Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Globalization and Health, 9(1), p. 62. https://doi.org/10.1186/1744-8603-9-62
  • Ferrario, Alessandra, Kanavos, Panos (2013). The LSE Summit: risk sharing and managed entry agreements.
  • Godman, Brian B., Finlayson, Alexander E., Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Iñaki, Jones, Janelle M., Malmström, Rickard E., Asola, Elina, Baumgärtel, Christoph & Bennie, Marion et al (2013). Personalizing health care: feasibility and future implications. BMC Medicine, 11(1), p. 179. https://doi.org/10.1186/1741-7015-11-179
  • Ferrario, Alessandra, Kanavos, Panos (2013). Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease.
  • Kanavos, Panos, Ferrario, Alessandra, Vandoros, Sotiris, Anderson, Gerard F. (2013). Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs, 32(4), 753-761. https://doi.org/10.1377/hlthaff.2012.0920
  • Ferrario, Alessandra, Kanavos, Panos (2013). Managed entry agreements for pharmaceuticals: the European experience. EMiNet.
  • Deerochanawong, Chaicharn, Ferrario, Alessandra (2013). Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Globalization and Health, 9(1), p. 11. https://doi.org/10.1186/1744-8603-9-11
  • Malmström, Rickard E., Godman, Brian B., Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen & Ferrario, Alessandra et al (2013). Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4(39). https://doi.org/10.3389/fphar.2013.00039
  • Ferrario, Alessandra, Coast, Ernestina (2012). Setting the agenda for global family planning: a pre-summit discussion at the LSE.
  • Sautenkova, Nina, Ferrario, Alessandra, Bolokhovets, Ganna, Kanavos, Panos (2012). Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova: final report. (Health policy paper series no. 6). World Health Organization. Regional Office for Europe.
    • Psychological and Behavioural Science
  • Ferrario, Alessandra, Kanavos, Panos (2013). Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease.
    • Social Policy
  • Ferrario, Alessandra (2017). Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden. European Journal of Health Economics, 18(9), 1095-1105. https://doi.org/10.1007/s10198-016-0855-5
  • Vogler, Sabine, Paris, Valérie, Ferrario, Alessandra, Wirtz, Veronika J., Joncheere, Kees de, Schneider, Peter, Pedersen, Hanne Bak, Dedet, Guillaume, Babar, Zaheer-Ud-Din (2017). How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries. Applied Health Economics and Health Policy, 15(3), 307-321. https://doi.org/10.1007/s40258-016-0300-z
  • Ferrario, Alessandra (2016). Access to cancer medicines in Europe: an analysis of existing challenges and countries’ responses [Doctoral thesis]. London School of Economics and Political Science. https://doi.org/10.21953/lse.j188ab43d54r
  • Ferrario, Alessandra, Reinap, Marge, Pedersen, Hanne Bak, Kanavos, Panos (2016). Availability of medicines in Estonia: an analysis of existing barriers and options to address them. World Health Organization.
  • Ferrario, Alessandra, Kanavos, Panos (2015). Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124, 39-47. https://doi.org/10.1016/j.socscimed.2014.11.003 picture_as_pdf
  • Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J, Babar, Zaheer-Ud-Din (2015). Challenges and opportunities for pharmaceutical pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice, 8(Suppl). https://doi.org/10.1186/2052-3211-8-S1-E1
  • Ferrario, Alessandra, Baltezarević, Dragana, Novakovic, Tanja, Parker, Mark, Samardzic, Janko (2014). Evidence-based decision making in healthcare in Central Eastern Europe. Expert Review of Pharmacoeconomics and Outcomes Research, 14(5), 611-615. https://doi.org/10.1586/14737167.2014.946014
  • Skarphedinsdottir, Maria, Smith, Barton, Ferrario, Alessandra, Zues, Olga, Ciobanu, Angela, Tirdea, Marcela, Domente, Silviu, Habicht, Jarno (2014). Better noncommunicable disease outcomes: challenges and opportunities for health systems: Republic of Moldova country assessment. World Health Organization.
  • Kwong, Danica, Ferrario, Alessandra, Adamski, Jajub, Inotai, Andras, Kalo, Zoltan (2014). Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth, 20(2), 25-28.
  • Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos, Safta, Vladimir (2014). An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7(1), p. 4. https://doi.org/10.1186/2052-3211-7-4
  • Lamri, Larbi, Gripiotis, Erofile, Ferrario, Alessandra (2014). Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications. Globalization and Health, 10(1), p. 11. https://doi.org/10.1186/1744-8603-10-11
  • Soewondo, Pradana, Ferrario, Alessandra, Tahapary, Dicky Levenus (2013). Challenges in diabetes management in Indonesia: a literature review. Globalization and Health, 9(1), p. 63. https://doi.org/10.1186/1744-8603-9-63
  • Bertoldi, Andréa D., Kanavos, Panos, França, Giovanny V. A., Carraro, André, Tejada, Cesar Augusto, Hallal, Pedro C., Ferrario, Alessandra, Schmidt, Maria (2013). Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Globalization and Health, 9(1), p. 62. https://doi.org/10.1186/1744-8603-9-62
  • Ferrario, Alessandra, Kanavos, Panos (2013). The LSE Summit: risk sharing and managed entry agreements.
  • Godman, Brian B., Finlayson, Alexander E., Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Iñaki, Jones, Janelle M., Malmström, Rickard E., Asola, Elina, Baumgärtel, Christoph & Bennie, Marion et al (2013). Personalizing health care: feasibility and future implications. BMC Medicine, 11(1), p. 179. https://doi.org/10.1186/1741-7015-11-179
  • Kanavos, Panos, Ferrario, Alessandra, Vandoros, Sotiris, Anderson, Gerard F. (2013). Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs, 32(4), 753-761. https://doi.org/10.1377/hlthaff.2012.0920
  • Ferrario, Alessandra, Kanavos, Panos (2013). Managed entry agreements for pharmaceuticals: the European experience. EMiNet.
  • Malmström, Rickard E., Godman, Brian B., Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen & Ferrario, Alessandra et al (2013). Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4(39). https://doi.org/10.3389/fphar.2013.00039
  • Ferrario, Alessandra, Coast, Ernestina (2012). Setting the agenda for global family planning: a pre-summit discussion at the LSE.
  • Sautenkova, Nina, Ferrario, Alessandra, Bolokhovets, Ganna, Kanavos, Panos (2012). Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova: final report. (Health policy paper series no. 6). World Health Organization. Regional Office for Europe.